Diagnosis of the infectious complications of continuous ambulatory peritoneal dialysis by 99mTc-HMPAO labelled leukocytes;Diagnóstico de las complicaciones infecciosas de la diálisis peritoneal continua ambulatoria mediante leucocitos marcados con 99mTc-HMPAO

Revista Espanola de Medicina Nuclear

Volumn 23, Issue 6, 2004, Pages 403-413

  Ruiz Solis S ^a   Garcia Vicente A ^a   Rodado Marina, S ^a   De La Torre, M ^a   Cortes Romero M ^a   Poblete Garcia V ^a   Soriano Castrejon A ^a  

^a Servicio de Medicina Nuclear   (Spain)

Author keywords

Dialysis; Infectious complications; Peritoneum; Radiolabelled leukocytes; Radionuclides

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ABDOMINAL SCINTISCANNING; ADULT; AGED; ARTICLE; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HUMAN; LEUKOCYTE; MALE; PERITONEAL DIALYSIS; PERITONITIS;

EID: 10644293923     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13067826     Document Type: Article

References (41)

1. Nolph KD, Popovich RP, Ghods AJ, Twardowski ZJ. Determinants of low clearances of small solutes during peritoneal dialysis. Kidney Int 1978;13:117-23.
2. Montenegro J, Olivares J. Diálisis peritoneal en la insuficiencia renal crónica. In: Llach F, Valderrábano F, eds. Insuficiencia renal crónica. Diálisis y trasplante renal. Madrid: Ediciones Norma; 1997. p. 999-1047.
3. Vargemezis V, Thodis E. Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2001;16(Suppl 6):106-8.
4. Twardowski ZJ. Peritoneal catheter exit-site and tunnel infections. In: Nissenson AR, Fine RN, eds. Dialysis therapy, 2nd edition. Philadelphia: Hanley & Belfus, Inc; 1993. p. 165-8.
5. Keogh AM. Complications in peritoneal dialysis: peritonitis and exit-site infections. Perit Dial Int 1996;16:464-7.
6. Vas SI. Peritonitis in peritoneal dialysis patients. In: Nissenson AR, Fine RN, eds. Dialysis therapy, 2nd edition. Philadelphia: Hanley & Belfus, Inc; 1993. p. 168-71.
7. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labelling of phagocytic leukocytes. J Nucl Med 1976;17: 480-7.
8. 99mTc-hexamethyl-propylenamineoxime for labelling leukocytes and imaging inflammation. Lancet 1986;2:946-9.
9. 111In-oxine labelled granulocytes in man: fist clinical results. Nucl Med Commun 1988;9: 435-47.
10. Laitinen R, Tähtinen J, Lantto T, Vorne M. Tc-99m labeled leukocytes in imaging of patients with suspected acute abdominal inflammation. Clin Nucl Med 1990;15:597-602.
11. 99mTc-HMPAO". Rev Esp Med Nucl 1996;15:438-9.
12. 99mTc-HMPAO. Nycomed Amersham plc. Diciembre 1998.
13. 99mTc radiopharmaceuticals. Nucl Med Commun 1994;15:845-9.
14. 99mTc- hexamethylpropylenamine oxime. Nucl Med Commun 1988;9:465-75.
15. Mata F. Células sanguíneas marcadas con radionucleidos. Aspectos metodológicos. II. Leucocitos y linfocitos. Rev Esp Med Nucl 1996;15:121-8.
16. Mountford PJ, Kettle AG, O'Doherty MJ, Coakley AJ. Comparison of technetium-99m-HM-PAO leukocytes with indium-111-oxine leukocytes for localizing intraabdominal sepsis. J Nucl Med 1990;31:311-5.
17. Allan RA, Sladen GE, Bassingham S, Lazarus C, Clarke SE, Fogelman I. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease. Eur J Nucl Med 1993;20:195-200.
18. Vilien M, Nielsen SL, Jorgensen M, Binder V, Hvid-Jacobsen K, Berild D, et al. Leukocyte scintigraphy to localize inflammatory activity in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1992;27:582-6.
19. Kennan N, Hay ward M. Tc HMPAO-labeled white cell scintigraphy in Crohn's disease of the small bowel. Clin Radiol 1992; 45:331-4.
20. Li DJ, Middleton SJ, Wraight EP. 99mTc and 111In leukocyte scintigraphy in inflammatory bowel disease. Nucl Med Commun 1992;13;867-70.
21. Arndt JW, van der Sluys Veer A, Blok D, Griffoen G, Verspaget HW, Lamers CB, et al. Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease. J Nucl Med 1993;34:1052-7.
22. Charron M, Orenstein SR, Bhargava S. Detection of inflammatory bowel disease in pediatric patients with technetium-99m-HMPAO-labeled leukocytes. J Nucl Med 1994;35:451-5.
23. Twardowski ZJ, Prowant BF. Current approach to exit-site infections in patients on peritoneal dialysis. Nephrol Dial Transplant 1997;12:1284-95.
24. Gonthier D, Bernardini J, Holley JL, Piraino B. Erythema: does it indicate infection in a peritoneal catheter exit site? Adv Perit Dial 1992;8:230-3.
25. Vas SI. What are the indications for removal of the permanent peritoneal catheter? Perit Dial Bull 1981;1:150-3.
26. Piraino B. Infectious complications of peritoneal dyalisis. Perit Dial Int 1997;17[suppl 3]:S15-8.
27. Mansfield JC, Giaffer MH, Tindale WB, Holdsworth CD. Quantitative assessment of overall inflammatory bowel disease activity using labelled leukocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods. Gut 1995;37: 679-83.
28. De Lima PA, Martin-Comin J, Muñoz A, Baliellas C, Vilar L, Roca M, et al. Comparison of endoscopy, radiology and scintigraphy with Tc-99m-exametazine labeled leukocytes and In-111 labeled human polyclonal immunoglobulin G in the diagnosis of inflammatory bowel disease. Med Clin (Barc) 1998;111:241-6.
29. Peters AM. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994;24:110-27.
30. Rachinsky I, Bogulavsky L, Goldstein D, Golan H, Pak I, Katz M, et al. Diagnosis of pyogenic pelvic inflammatory diseases by 99mTc-HMPAO leukocyte scintigraphy. Eur J Nucl Med 2000;27:1774-7.
31. Ascher NL, Ahrenholz DH, Simmons RL, Weiblen B, Gomez L, Forstrom LA, et al. Indium 111 autologous tagged leukocytes in the diagnosis of intraperitoneal sepsis. Arch Surg 1979;114: 386-92.
32. Baba AA, McKillop JH, Cuthbert GF, Neilson W, Gray HW, Anderson JR. Indium 111 leukocyte scintigraphy in abdominal sepsis. Do the results affect management? Euro J Nucl Med 1990;16:307-8.
33. Navarro DA, Weber PM, Kang IY, dos Remedios LV, Jasko IA, Sawicki JE. Indium-111 leukocyte imaging in appendicitis. Am J Roentgenol 1987;148:733-6.
34. Palestro CJ, Vega A, Kim CK, Vallabhajosula S, Goldsmith SJ. Indium-111-labeled leukocyte scintigraphy in hemodialysis access-site infection. J Nucl Med 1990;31:319-24.
35. Meller J, Sahlmann CO, Becker W. Nuclear medicine studies in the dyalisis patient. Semin Dial 2002;15:269-76.
36. Steiner RW, Kipper S, Savoia MC, Witztum KF. Identification of peritoneal dialysis catheter tunnel infection by scanning with Indium-111-labeled leukocytes. Ann Intern Med 1983;99:44-5.
37. Kipper SL, Steiner RW, Witztum KF, Basarab RM, Kipper MS, Halpern SE, et al. In-111-leukocyte scintigraphy for detection of infection associated with peritoneal dialysis catheters. Radiology 1984;151:491-4.
38. Cendoroglo M, Sundaram S, Jaber BL, Pereira BJ. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Am J Kidney Dis 1998;31:273-82.
39. Jin HM, Di YD, Xu QJ. Effects of commercial glucose-based peritoneal dialysates on peripheral blood phagocytes apoptosis. Perit Dial Int 1999;19(Suppl 2):S388-93.
40. Malacarne F, De Paoli Vitali E, Prandini N, Feggi L, Perini L, Cervi PM, et al. Increased uptake of radio labelled white blood cells into abdomen of uremics on peritoneal dialysis. Adv Perit Dial 1992;8:39-41.
41. Vychytil A, Lilaj T, Lorenz M, Hörl WH, Haag-Weber M. Ultrasonography of the catheter tunnel in peritoneal dialysis patients: what are the indications? Am J Kidney Dis 1999;33: 722-7.